Publié le Laisser un commentaire

A Botanical Extract Extends Lifespan and Healthspan in Mice

According to a new study, a polyphenol-rich natural extract positively impacts lifespan, healthspan, and cellular senescence. These results were observed in both cell culture and a mouse model [1].

From folk medicine to modern science

Traditional and folk medicines offer many botanical extracts that can be tested by modern science for their medicinal properties and influences on aging. One such plant is the Bolivian prawn sage (Salvia haenkei).

Salvia haenkei is a fast growing perennial plant with aromatic leaves and upright stems of red, prawn-like flowers. It is native to Bolivia and southern Peru and is found in the seasonally dry tropical environment of those countries.

This study’s authors had previously screened botanical extracts and discovered that an extract from Salvia haenkei delays cellular senescence in human cell cultures [2]. The extract is called Haenkenium (HK).

Longer and healthier lives

In this study, the authors administered HK to the drinking water of 20-month-old mice until the ends of their lives. The mice that consumed HK lived longer than the control group: a median lifespan of 32.25 months compared to 28 months.

This lifespan effect was sex-independent, as both male and female mice treated with HK had longer lifespans. The researchers also reported no observed signs of toxicity.

Improvements in lifespan were accompanied by improvements in healthspan, as HK-treated animals’ age-related phenotypes were improved compared to the control group.

Those phenotypes included abnormal rounding of the upper back (kyphosis), tumor development, fur quality, bone structure, grip strength, and kidney function. In other words, not only did the mice live longer, they were also healthier.

Impacts on gene expression

The authors compared muscle-specific gene expression between young and old animals. They also analyzed the impact of HK treatment on age-related gene expression changes.

The analysis identified genes that are upregulated and downregulated during aging. In mice treated with HK, they observed comparative downregulation of aging-upregulated genes and upregulation of aging-downregulated genes.

The researchers also noted the molecular pathways and processes of these age-related gene expression changes, which included inflammation, immune activation, cellular senescence, and the senescence-associated secretory phenotype (SASP).

In mice treated with HK, these pathways were relatively suppressed. To be certain, the researchers used multiple methods to confirm these findings in different tissues.

Beyond aging

Cellular senescence can result from natural aging or can be induced by stressors, such as chemotherapy [3]. Since HK was effective in ameliorating the effects of senescence caused by aging, the researchers hypothesized that it could be effective in ameliorating the effects of chemotherapy on senescence.

They treated the mice with doxorubicin, a potent chemotherapeutic agent that induces cellular senescence [4]. The mice treated with doxorubicin that also consumed water with HK had fewer accumulated senescent cells and didn’t lose as much body weight as the controls.

Doxorubicin is also known for causing cardiac dysfunction by inducing senescence in cardiac tissue [5]. In this study, the researchers induced senescence with doxorubicin in human-induced cardiomyocyte cells and then treated them with HK. HK treatment significantly reduced senescence in those cells. However, as researchers caution, there is still a need to test the impact of HK on chronic exposure to doxorubicin to better reflect clinical settings.

Finding the active component

Since the HK extract has shown such promising results, the researchers were curious about which component of this botanical extract is responsible for those effects. They identified several groups of molecules in the extract, including phenols/lignans, flavonoids, and terpenes. Previous research reported that flavonoids can modulate cellular senescence [6, 7]; the researchers decided to focus mainly on this group for further exploration.

Testing several flavonoids present in HK revealed that three had an impact on senescence that were similar to overall HK treatment. Among those three, luteolin and its derivatives account for 1.33% of the HK extract, making it the most prevalent flavonoid.

Subsequent experiments, in cell culture and mice, have shown that luteolin acted similarly to HK in preventing the accumulation of senescent cells after senescence induction by UV or doxorubicin, which suggests that luteolin is a key component of HK.

On the molecular level, the researchers identified that luteolin binds to the cell cycle regulator CDK6 and disrupts binding between the cell cycle inhibitor p16 and CDK6. The increase in p16 plays a part in developing senescence by blocking CDK6 activity and inhibiting the cell cycle [8]. The researchers suggest that this is luteolin’s mechanism of action in preventing or delaying the onset of senescence.

Strengths and weaknesses

Luteolin, identified in this study as an active compound with anti-senescence properties, is not only found in HK but in many edible vegetables and herbs and has been described previously to have antioxidant, anti-inflammatory, and anticancer properties [9, 10], which makes it an interesting candidate for further studies and clinical trials.

The researchers point out that contrary to many studies of different compounds, the dose they used is low, which makes it a promising candidate for use as a supplement or in pharmaceuticals. Additionally, those researchers have demonstrated that even treatment started relatively later in life can still show many beneficial effects, which makes it promising for humans. However, the researchers focused on a limited number of age-associated phenotypes, and further research is needed to assess if HK also impacts different aspects of aging.

This paper focused on luteolin and its anti-senescence properties, but other components of HK may also significantly contribute to lifespan and healthspan extension, which requires further investigation.

Lastly, the authors caution that their study involved experiments done on inbred mice, and further research should confirm if these effects are also observed in a more genetically heterogeneous population.

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future.

Literature

[1] Zumerle, S., Sarill, M., Saponaro, M., Colucci, M., Contu, L., Lazzarini, E., Sartori, R., Pezzini, C., Rinaldi, A., Scanu, A., Sgrignani, J., Locatelli, P., Sabbadin, M., Valdata, A., Brina, D., Giacomini, I., Rizzo, B., Pierantoni, A., Sharifi, S., . . . Alimonti, A. (2024). Targeting senescence induced by age or chemotherapy with a polyphenol-rich natural extract improves longevity and healthspan in mice. Nature Aging.

[2] Matic, I., Revandkar, A., Chen, J., Bisio, A., Dall’Acqua, S., Cocetta, V., Brun, P., Mancino, G., Milanese, M., Mattei, M., Montopoli, M., & Alimonti, A. (2016). Identification of Salvia haenkei as gerosuppressant agent by using an integrated senescence-screening assay. Aging, 8(12), 3223–3240.

[3] Demaria, M., O’Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., Alston, S., Academia, E. C., Kilmarx, S., Valdovinos, A., Wang, B., de Bruin, A., Kennedy, B. K., Melov, S., Zhou, D., Sharpless, N. E., … Campisi, J. (2017). Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse. Cancer discovery, 7(2), 165–176.

[4] Ludke, A., Akolkar, G., Ayyappan, P., Sharma, A. K., & Singal, P. K. (2017). Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C. PloS one, 12(7), e0179452.

[5] Lazzarini, E., Lodrini, A. M., Arici, M., Bolis, S., Vagni, S., Panella, S., Rendon-Angel, A., Saibene, M., Metallo, A., Torre, T., Vassalli, G., Ameri, P., Altomare, C., Rocchetti, M., & Barile, L. (2022). Stress-induced premature senescence is associated with a prolonged QT interval and recapitulates features of cardiac aging. Theranostics, 12(11), 5237–5257.

[6] Fan, X., Fan, Z., Yang, Z., Huang, T., Tong, Y., Yang, D., Mao, X., & Yang, M. (2022). Flavonoids-Natural Gifts to Promote Health and Longevity. International journal of molecular sciences, 23(4), 2176.

[7] Lim, H., Park, H., & Kim, H. P. (2015). Effects of flavonoids on senescence-associated secretory phenotype formation from bleomycin-induced senescence in BJ fibroblasts. Biochemical pharmacology, 96(4), 337–348.

[8] Campisi, J., & d’Adda di Fagagna, F. (2007). Cellular senescence: when bad things happen to good cells. Nature reviews. Molecular cell biology, 8(9), 729–740.

[9] Gendrisch, F., Esser, P. R., Schempp, C. M., & Wölfle, U. (2021). Luteolin as a modulator of skin aging and inflammation. BioFactors (Oxford, England), 47(2), 170–180.

[10] Seelinger, G., Merfort, I., Wölfle, U., & Schempp, C. M. (2008). Anti-carcinogenic effects of the flavonoid luteolin. Molecules (Basel, Switzerland), 13(10), 2628–2651.

Publié le Laisser un commentaire

A4LI Responds to NIH Reform Proposal

August 5, 2024 WASHINGTON, DC — The Alliance for Longevity Initiatives (A4LI) is proposing a new National Institute for Longevity and Aging Research (NILAR) in response to the recent NIH reform proposed by House Energy and Commerce (E&C) Chair Cathy McMorris-Rodgers.

(R-WA). While this new NIH framework aims to enhance clarity, transparency, oversight, and reduce redundancy within the institute, the intent to shift the focus of the National Institute on Aging (NIA) to the National Institute on Dementia greatly affects our current progress in geroscience and longevity research. After six focus group sessions with their strategic partners in both academia and industry, A4LI drafted a well-thought out proposal to enhance the existing NIA, which will be submitted by the stakeholders feedback deadline on August 16, 2024.

With the rise of older adults of 60 years and older living with at least one or more chronic illness, it becomes increasingly imperative to be motivated by aging biology research and to expand on what the NIA has accomplished in the last 50 years. NILAR’s ultimate goal is to advance geroscience and longevity research and support the development of groundbreaking therapeutics that prevent multiple age-related conditions while emphasizing accountability and innovation within the institute.

With Congress prioritizing NIH reformation to better serve the needs of Americans, A4LI’s proposal of NILAR will strive to innovate research tools and develop therapies that prevent chronic illnesses and the cause of multimorbidity in older adults. While A4LI recognizes that an optimal outcome might involve the Energy and Commerce Committee not altering the NIA at all, this proposal may also serve as a blueprint for a new institute or as recommendations for enhancing the existing NIA.

Please sign to demonstrate your support for NILAR. If you have feedback that will strengthen this proposal, please reach out to Dylan or Brenda.

About the Alliance for Longevity Initiatives (A4LI)

The Alliance for Longevity Initiatives (A4LI) is an independent 501(c)(4) nonprofit organization committed to advancing legislation and policies that promote healthy human lifespan. With a focus on equitable access to next-generation therapies, A4LI brings together scientists, policymakers, and influencers to drive collaboration and innovation in the longevity biotech industry.

Disclaimer

Keith Comito serves both on the Lifespan.io and A4LI board of directors.

Publié le Laisser un commentaire

NMN Increases Lifespan in Female Mice

A new preprint from David Sinclair’s lab has discovered that NMN supplementation started in midlife increases median and maximal lifespan in female mice and boosts healthspan in males [1].

NAD and aging

Nicotinamide adenine dinucleotide (NAD) is a ubiquitous metabolite that performs several crucial roles. NAD’s oxidized version, NAD+, participates in energy production, facilitates DNA repair, and serves as a co-substrate for many enzymes, such as sirtuins, the family of proteins linked to longevity.

NAD+ levels decline with age, but they are not easy to replenish. While it is possible to get pure NAD+ intravenously, via patches, or as a nasal spray, a seemingly easier way is to use NAD+ precursors, such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). Numerous studies have shown that both can elevate NAD+ levels and produce various health benefits [2], such as improved mitochondrial function and lower inflammation.

When it comes to lifespan, NR has shown mixed results in mice. Notably, a vast study by the Intervention Testing Program, considered the golden standard of mouse lifespan studies, failed to demonstrate life extension by NR [3]. NMN’s effect on mammalian lifespan has not been tested until now. Both compounds are currently in multiple human trials and are marketed as supplements.

Long live the females!

In this new study, coming from the Harvard laboratory of the prominent geroscientist David Sinclair and currently under review by the journal Cell, mice of both sexes received NMN in their food starting at 13 months of age (roughly 40 in human years). The chosen daily dose was 550 mg/kg. Using a popular conversion formula based on body surface, this is equivalent to a human dose of 44 mg/kg, or about 3 grams for an average human.

Both male and female mice in the study group had lower frailty scores later in life. Males experienced less vision loss, maintained fur color and had better breathing rates compared to controls. Females enjoyed better coat condition and less kyphosis.

The same group of researchers recently developed a mouse biological age clock based on frailty metrics. “Application of these tools to the male mice at 21 months,” the researchers wrote, “showed the NMN-treated mice had lower predicted age, indicating lower biological age, and higher predicted remaining lifespan than untreated mice.” Methylation clocks, a more widely accepted metric of biological age, however, did not show a significant effect of NMN.

While the frailty-based clock showed lower biological age in male mice, the treatment did not translate into longer lifespan in this subgroup. It did, however, in female mice, extending median lifespan by 8.5% and maximal lifespan (measured at 90% mortality) by 7.9%. Many compounds tested for lifespan extension in mice have sex-specific effects, and the reasons for that are not clear yet.

“Despite the increased lifespan of the female mice,” the authors note, “there was no difference in disease burden or morbidity index between treated and untreated mice, implying a delay in the onset of age-related diseases generally with NMN treatment, rather than the targeting of a specific disease.”

Lower inflammation and better microbiome

While male mice didn’t get significant lifespan extension, their increased healthspan was consistent with the visible separation of survival curves up to the 24-month mark. Male mice stayed leaner on average and showed increased activity during dark time when mice are most active. Interestingly, many of the benefits seen in males were not detected in females. Their metabolome also showed much less changes in reaction to treatment than in males.

The treated mice of both sexes also had lower levels of 4 out of 31 inflammatory cytokines, suggesting the attenuation of age-related inflammation. The composite cytokine score showed a downward trend, which did not quite achieve statistical significance.

In another interesting finding, NMN caused changes in the microbiome. In particular, it increased the abundance of Anaerotruncus colihominis, a bacterial species that has been linked to lower neuroinflammation and is enriched in centenarians. This might explain some of NMN’s beneficial effects. However, the authors admit that “the mechanism of lifespan extension in female mice with NMN remains unclear.” It is also unclear why life extension was only observed in female mice, although the researchers did detect certain sex-related differences in NMN metabolism that might account for that.

“The beneficial effects of NMN on metabolism and its ability to delay frailty in mice were expected,” David Sinclair said to Lifespan.io, “but we didn’t expect to see apparently positive changes to the microbiome or sex differences in lifespan. We hope the work is useful in guiding the design of future clinical trials testing the effects of NMN and other NAD boosters in humans.”

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future.

Literature

[1] Kane, A. E., Chellappa, K., Schultz, M. B., Arnold, M., Li, J., Amorim, J., … & Sinclair, D. A. (2024). Long-term NMN treatment increases lifespan and healthspan in mice in a sex dependent manner. bioRxiv, 2024-06.

[2] Rajman, L., Chwalek, K., & Sinclair, D. A. (2018). Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell metabolism, 27(3), 529-547.

[3] Harrison, D. E., Strong, R., Reifsnyder, P., Kumar, N., Fernandez, E., Flurkey, K., … & Miller, R. A. (2021). 17‐a‐estradiol late in life extends lifespan in aging UM‐HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex. Aging cell, 20(5), e13328. Chicago